Congress should preserve the 340B Drug Pricing Program because of the many benefits to low-income and uninsured patients, the AHA said today in a statement submitted to the House Energy and Commerce Health Subcommittee. As part of its advocacy efforts on behalf of the 340B program, the AHA has released videos of hospital leaders describing how the program benefits their patients and communities. To watch the videos, tune in here.